Five million people globally have been confirmed to have died from COVID-19 since the first known patient was diagnosed with the SARS-like disease just 23 months ago in China. Infections from the fast-spreading coronavirus have now become the world’s third leading cause of death, after heart disease and stroke. Althoughread more

Pharmaceutical company Merck & Co and Ridgeback Biotherapeutics are reporting that their antiviral drug, molnupiravir, is showing promising signs of being effective at preventing severe cases of COVID-19 in patients with mild to moderate forms of the disease. Taken orally, the treatment could be used by patients in their ownread more